✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Lincoln Pharmaceuticals Ltd.

LINCOLN

Market Cap
₹1,168 Cr.
P/E
13.07

Lincoln Pharmaceuticals Ltd.

  • Lincoln Pharma
  • Bliss GVS Pharma
  • Shivalik Rasayan
  • TJI Pharma
FAQs on Lincoln Pharmaceuticals Ltd. Shareprice

Lincoln Pharma has given lower returns compared to its competitors.
Lincoln Pharma has grown at ~13.25% over the last 8yrs while peers have grown at a median rate of 22.46%

Yes, Lincoln Pharma is expensive.
Latest PE of Lincoln Pharma is 13.07, while 3 year average PE is 11.38.
Also latest EV/EBITDA of Lincoln Pharma is 12.2 while 3yr average is 9.22.

View FAQ's On Business
Growth Table
  • Lincoln Pharmaceuticals Ltd.
  • Bliss GVS Pharma
  • Shivalik Rasayan
Balance Sheet
  • Lincoln Pharmaceuticals Ltd.
  • Bliss GVS Pharma
  • Shivalik Rasayan
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Lincoln Pharmaceuticals Ltd.
  • Bliss GVS Pharma
  • Shivalik Rasayan
Cash Flow
  • Lincoln Pharmaceuticals Ltd.
  • Bliss GVS Pharma
  • Shivalik Rasayan
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Lincoln Pharmaceuticals Ltd.
  • Bliss GVS Pharma
  • Shivalik Rasayan
Quarterly Results
  • Lincoln Pharmaceuticals Ltd.
  • Bliss GVS Pharma
  • Shivalik Rasayan
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Lincoln Pharmaceuticals Ltd. Financials

Balance sheet of Lincoln Pharma is strong.
It shouldn't have solvency or liquidity issues.

The debt of Lincoln Pharma is decreasing.
Latest debt of Lincoln Pharma is -₹31.56 Crs as of Sep-24.
This is less than Mar-24 when it was -₹26.03 Crs.

The profit is oscillating.
The profit of Lincoln Pharma is ₹89.37 Crs for TTM, ₹93.3 Crs for Mar 2024 and ₹72.9 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Lincoln Pharma latest dividend payout ratio is 3.86% and 3yr average dividend payout ratio is 4.11%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech